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Abstract The National Health System in the UK has evolved
to become one of the largest healthcare systems in the world. At
the time of writing of this review (August 2010) the UK
government in its 2010 White Paper “Equity and excellence:
Liberating the NHS” has announced a strategy on how it will
“create a more responsive, patient-centred NHS which achieves
outcomes that are among the best in the world”. This review
article presents an overview of the UK healthcare system as it
currently stands, with emphasis on Predictive, Preventive and
Personalised Medicine elements. It aims to serve as the basis for
future EPMA articles to expand on and present the changes that
will be implementedwithin theNHS in the forthcomingmonths.
Keywords UK .Healthcare system . National health
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Introduction
The UK healthcare system, National Health Service
(NHS), came into existence in the aftermath of the
Second World War and became operational on the 5th
July 1948. It was first proposed to the Parliament in the
1942 Beveridge Report on Social Insurance and Allied
Services and it is the legacy of Aneurin Bevan, a former
miner who became a politician and the then Minister of
Health. He founded the NHS under the principles of
universality, free at the point of delivery, equity, and paid
for by central funding [1]. Despite numerous political and
organisational changes the NHS remains to date a service
available universally that cares for people on the basis of
need and not ability to pay, and which is funded by taxes
and national insurance contributions.
Health care and health policy for England is the
responsibility of the central government, whereas in
Scotland, Wales and Northern Ireland it is the responsi-
bility of the respective devolved governments. In each of
the UK countries the NHS has its own distinct structure
and organisation, but overall, and not dissimilarly to
other health systems, healthcare comprises of two broad
sections; one dealing with strategy, policy and manage-
ment, and the other with actual medical/clinical care
which is in turn divided into primary (community care,
GPs, Dentists, Pharmacists etc.), secondary (hospital-
based care accessed through GP referral) and tertiary care
(specialist hospitals). Increasingly distinctions between
the two broad sections are becoming less clear. Particu-
larly over the last decade and guided by the “Shifting the
Balance of Power: The Next Steps” (2002) and “Wanless”
(2004) reports, gradual changes in the NHS have led to a
greater shift towards local rather than central decision
making, removal of barriers between primary and
secondary care and stronger emphasis on patient choice
[2, 3]. In 2008 the previous government reinforced this
direction in its health strategy “NHS Next Stage Review:
High Quality Care for All” (the Darzi Review), and in
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2010 the current government’s health strategy, “Equity and
excellence: Liberating the NHS”, remains supportive of
the same ideas, albeit through possibly different mecha-
nisms [4, 5].
The UK government has just announced plans that
according to some will produce the most radical change in
the NHS since its inception. In the 12th July 2010 White
Paper “Equity and excellence: Liberating the NHS”, the
current Conservative-Liberal Democrat coalition govern-
ment outlined a strategy on how it will “create a more
responsive, patient-centred NHS which achieves outcomes
that are among the best in the world” [5].
This review article will therefore present an overview of
the UK healthcare system as it currently stands with the aim
to serve as the basis for future EPMA articles to expand and
present the changes that will be implemented within the
NHS in the forthcoming months.
The NHS in 2010
The Health Act 2009 established the “NHS Constitution”
which formally brings together the purpose and principles
of the NHS in England, its values, as they have been
developed by patients, public and staff and the rights,
pledges and responsibilities of patients, public and staff [6].
Scotland, Northern Ireland and Wales have also agreed to a
high level statement declaring the principles of the NHS
across the UK, even though services may be provided
differently in the four countries, reflecting their different
health needs and situations.
The NHS is the largest employer in the UK with over 1.3
million staff and a budget of over £90 billion [7, 8]. In 2008
the NHS in England alone employed 132,662 doctors, a 4%
increase on the previous year, and 408,160 nursing staff
(Table 1). Interestingly the Kings Fund estimates that, while
the total number of NHS staff increased by around 35%
between 1999 and 2009, over the same period the number
of managers increased by 82%. As a proportion of NHS
staff, the number of managers rose from 2.7 per cent in
1999 to 3.6 per cent in 2009 (www.kingsfund.org.uk). In
2007/8, the UK health spending was 8.5% of Gross
Domestic Product (GDP)—with 7.3% accounting for public
and 1.2% for private spending. The net NHS expenditure
per head across the UK was lowest in England (£1,676) and
highest in Scotland (£1,919) with Wales and Northern
Ireland at approximately the same level (£1,758 and
£1,770, respectively) [8].
The overall organisational structure of the NHS in
England, Scotland, Wales and Northern Ireland in 2010 is
shown in Fig. 1. In England the Department of Health is
responsible for the direction of the NHS, social care and
public health and delivery of healthcare by developing
policies and strategies, securing resources, monitoring
performance and setting national standards [9]. Currently,
10 Strategic Health Authorities manage the NHS at a local
level, and Primary Care Trusts (PCTs), which currently
control 80% of the NHS’ budget, provide governance and
commission services, as well as ensure the availability of
services for public heath care, and provision of community
services. Both, SHAs and PCTs will cease to exist once the
plans outlined in the 2010 White Paper become imple-
mented (see section below). NHS Trusts operate on a
“payment by results” basis and obtain most of their income
by providing healthcare that has been commissioned by the
practice-based commissioners (GPs, etc.) and PCTs. The
main types of Trusts include Acute, Care, Mental Health,
Ambulance, Children’s and Foundation Trusts. The latter
were created as non-profit making entities, free of govern-
ment control but also increased financial obligations and
are regulated by an independent Monitor. The Care Quality
Commission regulates independently health and adult social
care in England overall. Other specialist bodies provide
financial (e.g. Audit Commission, National Audit Office),
treatment/services (e.g. National Patient Safety Agency,
Medicines and Healthcare Products Regulatory Agency)
and professional (e.g. British Medical Association) regula-
tion. The National Institute for Health and Clinical
NHS main staff groups No. of staff % of total NHS workforce
All doctors 132,662 9.6
Qualified ambulance staff 17,451 1.2
Scientific, therapeutic & technical staff 142,558 10.4
Qualified nursing staff 408,160 29.8
Support to clinical staff 355,010 25.9
Support to GPs 58,572 4.3
NHS infrastructure 219,064 16
Other GP practice staff 92,436 6.8
Other 353 0.02
Total 1,368,693 100
Table 1 The distribution of
NHS workforce according to
main staff groups in the UK in
2008 (NHS Information Centre:
www.ic.nhs.uk)
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Excellence (NICE) was established in 1999 as the body
responsible for developing national guidelines and stand-
ards related to, health promotion and prevention, assess-
ment of new and existing technology (including medicines
and procedures) and treatment and care clinical guidance,
available across the NHS. The health research strategy of
the NHS is being implemented through National Institute of
Health Research (NIHR), the total budget for which was in
2009/10 close to £1 billion (www.nihr.ac.uk) [10].
Section 242 of the NHS Act states that Trusts have a
legal duty to engage and involve patients and the public.
Patient experience information/feedback is formally gath-
ered nationally by annual survey (by the Picker Institute)
and is part of the NHS Acute Trust performance frame-
work. The Patient Advice Liaison Service (PALS) and
Local Involvement Networks (LINks) support patient
feedback and involvement. Overall, inpatients and out-
patients surveys have revealed that patients rate the care
they receive in the NHS high and around three-quarters
indicate that care has been very good or excellent [11].
In Scotland, NHS Boards have replaced Trusts and provide
an integrated system for strategic direction, performance
management and clinical governance, whereas in Wales, the
National Delivery Group, with advice from the National
Advisory Board, is the body performing these functions
(www.show.scot.nhs.uk; www.wales.nhs.uk). Scottish NHS
and Special Boards deliver services, with care for specific
conditions delivered through Managed Clinical Networks.
Clinical guidelines are published by the Scottish Intercolle-
giate Guidelines Network (SIGN) and the Scottish Medi-
cines Consortium (SMC) advices on the use of new drugs in
the Scottish NHS. In Wales, Local Heath Boards (LHBs)
plan, secure and deliver healthcare services in their areas and
there are 3 NHS Trusts providing emergency, cancer care
and public health services nationally. In Northern Ireland, a
single body, the Health and Care Board is overseeing
commissioning, performance and resource management and
improvement of healthcare in the country and six Health and
Social Care Trusts deliver these services (www.hscni.net). A
number of health agencies support ancillary services and
deal with a wide range of health and care issues including
cancer screening, blood transfusion, public health etc. In
Wales Community Health Councils are statutory lay bodies
advocating the interests of the public in the health service in
their district and in Northern Ireland the Patient and Client
Council represent patients, clients and carers.
Predictive, Preventive and Personalised Medicine
(PPPM) in the NHS
Like other national healthcare systems, predictive, pre-
ventive and/or personalised medicine services within the
NHS have traditionally been offered and are part of
disease diagnosis and treatment. Preventive medicine,
unlike predictive or personalised medicine, is its own
established entity and relevant services are directed by
Public Health and offered either via GP, community
services or hospitals. Patient-tailored treatment has
always been common practice for good clinicians in the
UK and any other healthcare system. The terms predic-
tive and personalised medicine though are evolving to
describe a much more technologically advanced way of
diagnosing disease and predicting response to the
standard of care, in order to maximise the benefit for
the patient, the public and the health system.
References to predictive and personalised medicine are
increasingly being introduced in NHS related information.
The NHS Choices website describes how patients can
obtain personalised advice in relation to their condition, and
offers information on predictive blood test for disease such
as TB or diabetes. The NIHR through NHS-supported
research and together with academic and commercial
collaborating networks is investing a significant proportion
of its budget in validating predictive and preventive
therapeutic interventions [10]. The previous government
considered the development of preventive, people-centred
and more productive healthcare services as the means for
the NHS to respond to the challenges that all modern
healthcare systems are facing in the 21st century, namely,
high patient expectation, ageing populations, harnessing of
information and technological advancement, changing
workforce and evolving nature of disease [12]. Increased
emphasis on quality (patient safety, patient experience and
clinical effectiveness) has also supported innovation in
early diagnosis and PPPM-enabling technologies such as
telemedicine.
A number of preventive services are delivered through
the NHS either via GP surgeries, community services or
hospitals depending on their nature and include:
& The Cancer Screening programmes in England are
nationally coordinated and include Breast, Cervical
and Bowel Cancer Screening. There is also an informed
choice Prostate Cancer Risk Management programme
(www.cancerscreening.nhs.uk).
& The Child Health Promotion Programme is dealing with
issues from pregnancy and the first 5 years of life and is
delivered by community midwifery and health visiting
teams [13].
& Various immunisation programmes from infancy to
adulthood, offered to anyone in the UK for free and
generally delivered in GP surgeries.
The Darzi review set out six key clinical goals in relation to
improving preventive care in the UK including, 1) tackling
obesity, 2) reducing alcohol harm, 3) treating drug addiction,
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4) reducing smoking rates, 5) improving sexual health and 6)
improving mental health. Preventive programmes to address
these issues have been in place over the last decades in
different forms and through different initiatives, and include:
& Assessment of cardiovascular risk and identification of
people at higher risk of heart disease is generally
preformed through GP surgeries.
& Specific preventive programmes (e.g. suicide, accident)
in local schools and community
& Family planning services and prevention of sexually
transmitted disease programmes, often with a emphasis
on young people
& A variety of prevention and health promotion pro-
grammes related to lifestyle choices are delivered
though GPs and community services including, alcohol
and smoking cessation programmes, promotion of
healthy eating and physical activity. Some of these
have a specific focus such as health promotion for older
people (e.g. Falls Prevention).
White paper 2010 – Equity and excellence: liberating
the NHS
The current government’s 2010 “Equity and excellence:
Liberating the NHS” White Paper has set out the vision of
the future of an NHS as an organisation that still remains
true to its founding principle of, available to all, free at the
point of use and based on need and not ability to pay. It also
continues to uphold the principles and values defined in the
NHS Constitution. The future NHS is part of the Govern-
ment’s Big Society which is build on social solidarity and
entails rights and responsibilities in accessing collective
healthcare and ensuring effective use of resources thus
delivering better health. It will deliver healthcare outcomes
that are among the best in the world. This vision will be
implemented through care and organisation reforms focus-
ing on four areas: a) putting patients and public first, b)
improving on quality and health outcomes, c) autonomy,
accountability and democratic legitimacy, and d) cut
bureaucracy and improve efficiency [5]. This strategy
makes references to issues that are relevant to PPPM which
indicates the increasing influence of PPPM principles
within the NHS.
According to the White Paper the principle of “shared
decision-making” (no decision about me without me) will be
at the centre of the “putting emphasis on patient and public
first” plans. In reality this includes plans emphasising the
collection and ability to access by clinicians and patients all
patient- and treatment-related information. It also includes
greater attention to Patient-Reported Outcome Measures,
greater choice of treatment and treatment-provider, and
importantly personalised care planning (a “not one size fits
all” approach). A newly created Public Health Service will
bring together existing services and place increased emphasis
on research analysis and evaluation. Health Watch England, a
body within the Care Quality Commission, will provide a
stronger patient and public voice, through a network of local
Health Watches (based on the existing Local Involvement
Networks - LINks).
The NHS Outcomes Framework sets out the priorities
for the NHS. Improving on quality and health outcomes,
according to the White Paper, will be achieved through
revising goals and healthcare priorities and developing
targets that are based on clinically credible and evidence-
based measures. NICE have a central role in developing
recommendations and standards and will be expected to
produce 150 new standards over the next 5 years. The
government plans to develop a value-based pricing system
for paying pharmaceutical companies for providing drugs
to the NHS. A Cancer Drug Fund will be created in the
interim to cover patient treatment.
The abolition of SHAs and PCTs, are being proposed as
means of providing greater autonomy and accountability.
GP Consortia supported by the NHS Commissioning Board
will be responsible for commissioning healthcare services.
The introduction of this type of “health management
organisations” has been somewhat controversial but possi-
bly not totally unexpected [14, 15]. The transfer of PCT
health improvement function to local authorities aims to
provide increased democratic legitimacy.
Challenges facing the UK healthcare system
Overall the health, as well as ideological and organisational
challenges that the UK Healthcare system is facing are not
dissimilar to those faced by many national healthcare
systems across the world. Life expectancy has been steadily
increasing across the world with ensuing increases in
chronic diseases such as cancer and neurological disorders.
Negative environment and lifestyle influences have created
a pandemic in obesity and associated conditions such as
diabetes and cardiovascular disease. In the UK, coronary
heart disease, cancer, renal disease, mental health services
for adults and diabetes cover around 16% of total National
Health Service (NHS) expenditure, 12% of morbidity and
between 40% and 70% of mortality [3]. Across Western
societies, health inequalities are disturbingly increasing,
with minority and ethnic groups experiencing most
serious illnesses, premature death and disability. The
House of Commons Health Committee warns that whilst
Fig. 1 Organisation of the NHS in England, Scotland, Wales and
Northern Ireland, in 2010
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the health of all groups in England is improving, over the
last 10 years health inequalities between the social
classes have widened—the gap has increased by 4% for
men, and by 11% for women—due to the fact that the
health of the rich is improving much quicker than that of
the poor [16]. The focus and practice of healthcare
services is being transformed from traditionally offering
treatment and supportive or palliative care to increasingly
dealing with the management of chronic disease and
rehabilitation regimes, and offering disease prevention
and health promotion interventions. Pay-for-performance,
changes in regulation together with cost-effectiveness and
pay for medicines issues are becoming a critical factor in
new interventions reaching clinical practice [17, 18].
Preventive medicine is solidly established within the UK
Healthcare System, and predictive and personalised
approaches are increasingly becoming so. Implementation of
PPPM interventions may be the solution but also the cause of
the health and healthcare challenges and dilemmas that health
systems such as the NHS are facing [19]. The efficient
introduction of PPPM requires scientific understanding of
disease and health, and technological advancement, together
with comprehensive strategies, evidence-based health poli-
cies and appropriate regulation. Critically, education of
healthcare professionals, patients and the public is also
paramount. There is little doubt however that harnessing
PPPM appropriately can help the NHS achieve its vision of
delivering healthcare outcomes that will be among the best
in the world.
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